Eligibility Criteria- INCLUSION CRITERIA:
This registry is open for all patients of all ages, male and female, with a confirmed diagnosis of Fabry disease.
Patients who are unwilling to give informed consent.
Patients who are receiving enzyme replacement therapy other than Replagal for Fabry Disease.
Patients currently enrolled in an ongoing blinded clinical trial in which the product is considered investigational.